# Feasibility Study of HIPEC for Patients With Stage III or Only Pleural Stage IV Ovarian Carcinoma in First Line Therapy

> **NCT01709487** · PHASE1,PHASE2 · COMPLETED · sponsor: **Jules Bordet Institute** · enrollment: 19 (actual)

## Conditions studied

- Ovarian Carcinoma
- Fallopian Tube Carcinoma
- Primary Peritoneal Carcinoma

## Interventions

- **PROCEDURE:** HIPEC

## Key facts

- **NCT ID:** NCT01709487
- **Lead sponsor:** Jules Bordet Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2015-10
- **Final completion:** 2015-10
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2016-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01709487

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01709487, "Feasibility Study of HIPEC for Patients With Stage III or Only Pleural Stage IV Ovarian Carcinoma in First Line Therapy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01709487. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*